FGF20 and Parkinson disease: Future work will consider alternative means of delivering FGF20 over a longer duration into the SNc for therapeutic exploration and will identify different approaches to boost the levels of endogenous FGF20 in the brain given the cells producing FGF20 are retained in PD (Tong et al., 2015).